Ropes & Gray has advised Spyre Therapeutics. Covington & Burling LLP has advised the underwriters. Spyre Therapeutics, Inc., a clinical-stage biotechnology company, has concluded a public...
Spyre Therapeutics Completes $316 Million Public Offering
Spyre Therapeutics’ $200 Million Common Stock Offering
Gibson Dunn & Crutcher advised Spyre Therapeutics, Inc. on the offering, and Covington & Burling advised the underwriters. Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (NASDAQ:...
Aeglea’s Acquisition of Spyre
Gibson, Dunn & Crutcher LLP is advising Spyre Therapeutics, Inc. in the transaction, while Cooley LLPis advising Aeglea. Aeglea BioTherapeutics, Inc. (“Aeglea”) (NASDAQ: AGLE), announced it has completed...